Do circulating tumor cells play a role in coagulation and thrombosis?

Frontiers in Oncology

Volumn 2 SEP, Issue , 2012, Pages

  Tormoen, Garth W ^a   Haley, Kristina M ^b   Levine, Ross L ^c   McCarty, Owen J T ^a,d  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood; Circulating tumor cells; Metastasis; Thrombosis; Tissue factor

Indexed keywords

BLOOD CLOTTING; CANCER PROGNOSIS; CIRCULATING TUMOR CELL; HUMAN; HYPERCOAGULABILITY; IMMUNOFLUORESCENCE; INCIDENCE; LEUKEMIA CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHORT SURVEY; THROMBOSIS;

EID: 84874682027     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00115     Document Type: Short Survey

References (61)

1. Akl, E. A., Labedi, N., Barba, M., Terrenato, I., Sperati, F., Muti, P., and Schüneann, H. (2011a). Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst. Rev. 6, CD006650.
2. Akl, E. A., Vasireddi, S. R., Gunukula, S., Yosuico, V. E., Barba, M., Terrenato, I., Sperati, F., and Schünemann, H. (2011b). Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst. Rev. 12, CD006466.
3. Allard, W. J., Matera, J., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G., Uhr, J. W., and Terstappen, L. W. (2004). Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897-6904.
4. Amirkhosravi, A., Mousa, S. A., Amaya, M., Blaydes, S., Desai, H., Meyer, T., and Francis, J. L. (2003). Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb. Haemost. 90, 549-554.
5. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., and Sporn, M. B. (1983). Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155-7160.
6. Barbui, T., and Falanga, A. (2001). Disseminated intravascular coagulation in acute leukemia. Semin. Thromb. Hemost. 27, 593-604.
7. Barbui, T., Finazzi, G., and Falanga, A. (1998). The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 91, 3093-3102.
8. Baron, J. A., Gridley, G., Weiderpass, E., Nyrén, O., and Linet, M. (1998). Venous thromboembolism and cancer. Lancet 351, 1077-1080.
9. Barrowcliffe, T. W., Fabregas, P., Jardi, M., Cancelas, J., Rabaneda, M., and Felez, J. (2002). Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb. Haemost. 87, 442-449.
10. Berny-Lang, M. A., Aslan, J. E., Tormoen, G. W., Patel, I. A., Bock, P. E., Gruber, A., and McCarty, O. J. (2011). Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys. Biol. 8, 015014.
11. Blom, J. W., Osanto, S., and Rosendaal, F. R. (2004). The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J. Thromb. Haemost. 2, 1760-1765.
12. De Stefano, V., Sora, F., Rossi, E., Chiusolo, P., Laurenti, L., Fianchi, L., Zini, G., Pagano, L., Sica, S., and Leone, G. (2005). The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J. Thromb. Haemost. 3, 1985-1992.
13. Dimopoulos, M. A., and Eleutherakis-Papaiakovou, V. (2004). Adverse effects of thalidomide administration in patients with neoplastic diseases. Am. J. Med. 117, 508-515.
14. Elice, F., Rodeghiero, F., Falanga, A., and Rickles, F. R. (2009). Thrombosis associated with angiogenesis inhibitors. Best Pract. Res. Clin. Haematol. 22, 115-128.
15. Erpenbeck, L., Nieswandt, B., Schön, M., Pozgajova, M., and Schön, M. P. (2010). Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. J. Invest. Dermatol. 130, 576-586.
16. Falanga, A., and Barbui, T. (2001). Coagulopathy of acute promyelocytic leukemia. Acta Haematol. 106, 43-51.
17. Falanga, A., Barbui, T., and Rickles, F. R. (2008). Hypercoagulability and tissue factor gene upregulation in hematologic malignancies. Semin. Thromb. Hemost. 34, 204-210.
18. Falanga, A., and Marchetti, M. (2009). Venous thromboembolism in the hematologic malignancies. J. Clin. Oncol. 27, 4848-4857.
19. Falanga, A., and Rickles, F. R. (2003). Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract. Res. Clin. Haematol. 16, 463-482.
20. Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., and Murphy, S. (1973). Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer 11, 704-718.
21. Gasic, G. J., Gasic, T. B., and Stewart, C. C. (1968). Antimetastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. U.S.A. 61, 46-52.
22. Gemmell, C. H., Turitto, V. T., and Nemerson, Y. (1988). Flow as a regulator of the activation of factor X by tissue factor. Blood 72, 1404-1406.
23. Gil-Bernabe, A. M., Ferjancic, S., Tlalka, M., Zhao, L., Allen, P. D., Im, J. H., Watson, K., Hill, S. A., Amirkhosravi, A., Francis, J. L., Pollard, J. W., Ruf, W., and Muschel, R. J. (2012). Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119, 3164-3175.
24. Haynes, L. M., Dubief, Y. C., and Mann, K. G. (2012). Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow. J. Biol. Chem. 287, 5225-5234.
25. Hsieh, H. B., Marrinucci, D., Bethel, K., Curry, D. N., Humphrey, M., Krivacic, R. T., Kroener, J., Kroener, L., Ladanyi, A., Lazarus, N., Kuhn, P., Bruce, R. H., and Nieva, J. (2006). High speed detection of circulating tumor cells. Biosens. Bioelectron. 21, 1893-1899.
26. Im, J. H., Fu, W., Wang, H., Bhatia, S. K., Hammer, D. A., Kowalska, M. A., and Muschel, R. J. (2004). Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64, 8613-8619.
27. Karpatkin, S., Pearlstein, E., Ambrogio, C., and Coller, B. S. (1988). Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J. Clin. Invest. 81, 1012-1019.
28. Kepner, N., and Lipton, A. (1981). A mitogenic factor for transformed fibroblasts from human platelets. Cancer Res. 41, 430-432.
29. Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., and Francis, C. W. (2008). Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111, 4902-4907.
30. Kopp, H. G., Placke, T., and Salih, H. R. (2009). Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 69, 7775-7783.
31. Krivacic, R. T., Ladanyi, A., Curry, D. N., Hsieh, H. B., Kuhn, P., Bergsrud, D. E., Kepros, J. F., Barbera, T., Ho, M. Y., Chen, L. B., Lerner, R. A., and Bruce, R. H. (2004). A rare-cell detector for cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 10501-10504.
32. Ku, G. H., White, R. H., Chew, H. K., Harvey, D. J., Zhou, H., and Wun, T. (2009). Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 113, 3911-3917.
33. Lee, A., Tormoen, G. W., Kanso, E., McCarty, O. J., and Newton, P. K. (2012). Modeling and simulation of procoagulant circulating tumor cells in flow. Front. Oncol. 2:108. doi: 10.3389/fonc.2012.00108
34. Lee, B. J., Kim, J. H., Woo, S. H., Kim, J. H., Kim, D. H., and Yu, Y. S. (2011). Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways. Oncol. Rep. 26, 665-670.
35. Liu, Y., Chao, X., Gu, W., Hua, X., and Xu, N. (2008). Acute thrombosis in superior mesenteric artery as first symptom in a AML patient. Int. J. Gen. Med. 1, 7-9.
36. Liu, Y., Jiang, P., Capkova, K., Xue, D., Ye, L., Sinha, S. C., Mackman, N., Janda, K. D., and Liu, C. (2011). Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res. 71, 6492-6502.
37. Ma, Z., Zhang, T., Wang, R., Cheng, Z., Xu, H., Li, W., Wang, Y., and Wang, X. (2011). Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism. Int. J. Gynecol. Cancer 21, 616-624.
38. McCarty, O. J., Jadhav, S., Burdick, M. M., Bell, W. R., and Konstantopoulos, K. (2002). Fluid shear regulates the kinetics and molecular mechanisms of activation-dependent platelet binding to colon carcinoma cells. Biophys. J. 83, 836-848.
39. McCarty, O. J., Mousa, S. A., Bray, P. F., and Konstantopoulos, K. (2000). Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96, 1789-1797.
40. Menell, J. S., Cesarman, G. M., Jacovina, A. T., McLaughlin, M. A., Lev, E. A., and Hajjar, K. A. (1999). Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340, 994-1004.
41. Mohle, R., Green, D., Moore, M. A., Nachman, R. L., and Rafii, S. (1997). Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U.S.A. 94, 663-668.
42. Musil, D., and Krc, I. (2010). Migrating venous thrombosis in acute leukemia. Blood Coagul. Fibrinolysis 21, 365-367.
43. Nemerson, Y. (1968). The phospholipid requirement of tissue factor in blood coagulation. J. Clin. Invest. 47, 72-80.
44. Nierodzik, M. L., and Karpatkin, S. (2006). Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10, 355-362.
45. Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., and Degen, J. L. (2005). Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105, 178-185.
46. Phillips, K. G., Kolatkar, A., Rees, K. J., Rigg, R., Marrinucci, D., Luttgen, M., Bethel, K., Kuhn, P., and McCarty, O. J. (2012a). Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. Front. Oncol. 2:96. doi: 10.3389/fonc.2012.00096
47. Phillips, K. G., Velasco, C. R., Li, J., Kolatkar, A., Luttgen, M., Bethel, K., Duggan, B., Kuhn, P., and McCarty, O. J. (2012b). Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient. Front. Oncol. 2:72. doi: 10.3389/fonc.2012.00072
48. Pickering, W., Gray, E., Goodall, A. H., Ran, S., Thorpe, P. E., and Barrowcliffe, T. W. (2004). Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines. J. Thromb. Haemost. 2, 459-467.
49. Rickles, F. R., and Levine, M. N. (2001). Epidemiology of thrombosis in cancer. Acta Haematol. 106, 6-12.
50. Shao, B., Wahrenbrock, M. G., Yao, L., David, T., Coughlin, S. R., Xia, L., Varki, A., and McEver, R. P. (2011). Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118, 4015-4023.
51. Sorensen, H. T., Mellemkjaer, L., Olsen, J. H., and Baron, J. A. (2000). Prognosis of cancers associated with venous thromboembolism. N. Engl. J. Med. 343, 1846-1850.
52. Sorensen, H. T., Mellemkjaer, L., Steffensen, F. H., Olsen, J. H., and Nielsen, G. L. (1998). The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N. Engl. J. Med. 338, 1169-1173.
53. Tian, M., Wan, Y., Tang, J., Li, H., Yu, G., Zhu, J., Ji, S., Guo, H., Zhang, N., Li, W., Gai, J., Wang, L., Dai, L., Liu, D., Lei, L., and Zhu, S. (2011). Depletion of tissue factor suppresses hepatic metastasis and tumor growth in colorectal cancer via the downregulation of MMPs and the induction of autophagy and apoptosis. Cancer Biol. Ther. 12, 896-907.
54. Tormoen, G. W., Cianchetti, F., Bock, P., and McCarty, O. J. (2012). Development of coagulation factor probes for the identification of procoagulant circulating tumor cells. Front. Oncol. 2:110. doi: 10.3389/fonc.2012.00110
55. Tormoen, G. W., Rugonyi, S., Gruber, A., and McCarty, O. J. (2011). The role of carrier number on the procoagulant activity of tissue factor in blood and plasma. Phys. Biol. 8, 066005.
56. Trousseau, A. (1865). "Phlegmasia alba dolens," in Clinique Medicale de l'Hotel-Dieu de Paris, ed. A. Trousseau (Paris: The New Sydenham Society), 654-712.
57. Welsh, J., Smith, J. D., Yates, K. R., Greenman, J., Maraveyas, A., and Madden, L. A. (2012). Tissue factor expression determines tumour cell coagulation kinetics. Int. J. Lab. Hematol. 34, 396-402.
58. Xu, C., Gui, Q., Chen, W., Wu, L., Sun, W., Zhang, N., Xu, Q., Wang, J., and Fu, X. (2011). Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J. Exp. Clin. Cancer Res. 30, 63.
59. Yates, K. R., Welsh, J., Echrish, H. H., Greenman, J., Maraveyas, A., and Madden, L. A. (2011). Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expres-sed tissue factor, phosphatidylser ine and phosphatidylethanolamine. Blood Coagul. Fibrinolysis 22, 680-687.
60. Zacharski, L. R., Memoli, V. A., and Rousseau, S. M. (1986). Coagulation-cancer interaction in situ in renal cell carcinoma. Blood 68, 394-399.
61. Zacharski, L. R., Schned, A. R., and Sorenson, G. D. (1983). Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res. 43, 3963-3968.